# Zhejiang Hisun Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/zhejiang-hisun-pharmaceutical-co-ltd/38a26f64-d8df-4781-8322-3606f62da25d

> Inspection records and compliance data for Zhejiang Hisun Pharmaceutical Co., Ltd. in Taizhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Zhejiang Hisun Pharmaceutical Co., Ltd.
- FEI Number: 3007719313
- City: Taizhou
- State: None
- Country Name: China
- Address Line 1: 46 Waisha Rd., Jiaojiang District
- Zip Code: None
- Facility Type: API/Finished Drug Product Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1238621 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2024-06-21](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/f6ce3ffd-e027-48bf-bfdf-4f3879aa15f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2024
- [EMA GMP - Zhejiang Hisun Pharmaceutical Co., Ltd. - INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 - 2022-04-19](https://www.globalkeysolutions.net/records/ema/zhejiang-hisun-pharmaceutical-co-ltd/af958589-e931-44bd-9f0d-7851c5e1d6d3) — source: EMA, date: April 19, 2022
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.globalkeysolutions.net/records/483/zhejiang-hisun-pharmaceutical-co-ltd/43ac2a52-29ad-4d11-b102-c322a0e8e66b) — source: FDA, date: June 7, 2019
- [FDA Inspection 1096299 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/173f8cb1-f958-4ffe-ae3c-9ff0d8830ef2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2019
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11](https://www.globalkeysolutions.net/records/483/zhejiang-hisun-pharmaceutical-co-ltd/79173a11-bcaa-4b81-8e6b-2662fd1b9d1a) — source: FDA, date: August 11, 2017
- [FDA Inspection 1027076 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/628b40d4-2701-4654-b291-709cbf0dfd0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-07](https://www.globalkeysolutions.net/records/483/zhejiang-hisun-pharmaceutical-co-ltd/782a5325-2b6a-4fd5-a558-9bd88056c204) — source: FDA, date: August 7, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.globalkeysolutions.net/records/483/zhejiang-hisun-pharmaceutical-co-ltd/5bce805f-5cef-44fe-bc93-6f7b46060574) — source: FDA, date: January 19, 2017
- [FDA Inspection 998186 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/298ff408-5db4-463e-a0f2-e1b4d261a186) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-16](https://www.globalkeysolutions.net/records/483/zhejiang-hisun-pharmaceutical-co-ltd/52384d3b-e571-4eb3-93bb-9eb3742f8b98) — source: FDA, date: January 16, 2017
- [WARNING_LETTER - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.globalkeysolutions.net/records/warning_letter/zhejiang-hisun-pharmaceutical-co-ltd/1c80aaa0-7c21-48ef-8a73-80a5561a3e9f) — source: FDA, date: March 7, 2015
- [FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/7d5d3246-ba28-4a79-aae1-fbd352e18a7f) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- [FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/4b8ef772-c6a9-48f6-9b5a-7e135ff81fb4) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- [FDA Inspection 794437 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/898d790f-e12d-4b9f-92cd-671080ded110) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 794531 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/47bcf70f-774a-4330-8492-ffa2b0cd540e) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/cbe96857-716b-476b-8128-9dfe2f862a45) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.globalkeysolutions.net/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/17c50e77-ade6-41d1-9294-2857d56d0e2a) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012

## Related Companies

- [Smithfield Bioscience Inc](https://www.globalkeysolutions.net/companies/smithfield-bioscience-inc/f87613b8-a59a-4a6d-b412-9f2b145f397b)
- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.globalkeysolutions.net/companies/alps-pharmaceutical-industrial-co-ltd/b7368086-4ecc-4cbe-b942-494bb1340c79)
- [Bioiberica, SAU](https://www.globalkeysolutions.net/companies/bioiberica-sau/3984e671-30b1-4c37-b603-0e20b5a76b7d)
- [Fukuzyu Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de)
- [Kyowa Hakko Bio Co., Ltd.](https://www.globalkeysolutions.net/companies/kyowa-hakko-bio-co-ltd/4ab0756a-78b6-4060-8087-809db6e7941b)
- [Hetero Labs Limited](https://www.globalkeysolutions.net/companies/hetero-labs-limited/511d3250-3361-4a46-af69-a80476303c91)
- [Shenzhen Oriental Pharmaceutical Co Ltd](https://www.globalkeysolutions.net/companies/shenzhen-oriental-pharmaceutical-co-ltd/71227651-964f-4f33-a24b-5c0b0f6c92a0)
- [Henan Lihua Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/henan-lihua-pharmaceutical-co-ltd/0fcfa9cb-e461-4a79-b60a-20bd1198621a)
- [Kreative Organics Private Limited](https://www.globalkeysolutions.net/companies/kreative-organics-private-limited/a7ac8ac3-c335-4d67-ba2d-5cdc59181996)
- [Corden Pharma Bergamo SPA](https://www.globalkeysolutions.net/companies/corden-pharma-bergamo-spa/8f926414-d5ef-49c4-be33-d7c81dfc55ea)

## Related Officers

- [Thomas J. Cosgrove](https://www.globalkeysolutions.net/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
- [Lindsey M. Schwaigerjohann](https://www.globalkeysolutions.net/people/lindsey-m-schwaigerjohann/9cff2b61-0816-4d65-b90f-ed9c892b76f4)
- [President](https://www.globalkeysolutions.net/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [Lindsey M. Schweighann](https://www.globalkeysolutions.net/people/lindsey-m-schweighann/62867a7f-df29-43c9-8805-1bba582ce120)